A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25–35-impaired mouse cognitive function

[1]  Desmond O'Neill,et al.  Drug treatments in Alzheimer's disease. , 2016, Clinical medicine.

[2]  Ling Chen,et al.  Simvastatin prevents β-amyloid25–35-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate , 2015, Neuropharmacology.

[3]  A. Palmeri,et al.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines. , 2014, Biochemical pharmacology.

[4]  A. Sandoval,et al.  Whole-cell patch-clamp recordings of Ca2+ currents from isolated neonatal mouse dorsal root ganglion (DRG) neurons. , 2014, Cold Spring Harbor protocols.

[5]  Ling Chen,et al.  Simvastatin Exerts Antiamnesic Effect in Aβ25‐35‐Injected Mice , 2014, CNS neuroscience & therapeutics.

[6]  B. Harvey,et al.  The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase. , 2014, Toxicology and applied pharmacology.

[7]  Abbas Ali Mahdi,et al.  Therapeutics of Alzheimer's disease: Past, present and future , 2014, Neuropharmacology.

[8]  J. Cummings,et al.  Biomarker‐Driven Therapeutic Management of Alzheimer's Disease: Establishing the Foundations , 2013, Clinical pharmacology and therapeutics.

[9]  M. D’Amelio,et al.  Neuroprotective effects of donepezil against cholinergic depletion , 2013, Alzheimer's Research & Therapy.

[10]  L. Zou,et al.  Protective effect of xanthoceraside against β-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells , 2013, Journal of Asian natural products research.

[11]  W. Klein,et al.  Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight Aβ Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers , 2013, The Journal of Neuroscience.

[12]  V. Vasić,et al.  Send Orders of Reprints at Reprints@benthamscience.net Acetylcholinesterase Inhibitors: Pharmacology and Toxicology , 2022 .

[13]  I. Vetter,et al.  Expression and Pharmacology of Endogenous Cav Channels in SH-SY5Y Human Neuroblastoma Cells , 2013, PloS one.

[14]  S. H. Kim,et al.  Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease , 2013, Neuropsychopharmacology.

[15]  J. Flores-Hernández,et al.  Potassium Current Is Not Affected by Long-Term Exposure to Ghrelin or GHRP-6 in Somatotropes GC Cells , 2013, Journal of biophysics.

[16]  Ling Chen,et al.  Anti-amnesic effect of neurosteroid PREGS in Aβ25–35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection , 2012, Neuropharmacology.

[17]  N. Pivovarova,et al.  Comparative Impact of Voltage-Gated Calcium Channels and NMDA Receptors on Mitochondria-Mediated Neuronal Injury , 2012, The Journal of Neuroscience.

[18]  M. Sabbagh,et al.  New Acetylcholinesterase Inhibitors for Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[19]  J. Quinn,et al.  Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine. , 2011, Biochimica et biophysica acta.

[20]  G. Taglialatela,et al.  Dysregulated phosphorylation of Ca2+/calmodulin‐dependent protein kinase II‐α in the hippocampus of subjects with mild cognitive impairment and Alzheimer’s disease , 2011, Journal of neurochemistry.

[21]  T. Nabeshima,et al.  Xanthoceraside attenuates amyloid β peptide25–35-induced learning and memory impairments in mice , 2011, Psychopharmacology.

[22]  S. Marchal,et al.  Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats. , 2011, The American journal of pathology.

[23]  F. Lung,et al.  Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide25-35, N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death , 2011, Psychopharmacology.

[24]  C. Volmar,et al.  Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier , 2011, Molecular medicine.

[25]  Christopher P. Chen,et al.  Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats , 2011, Drug Metabolism and Disposition.

[26]  J. Quinn,et al.  L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease , 2011, Neurobiology of Disease.

[27]  G. Ginani,et al.  Acute effects of donepezil in healthy young adults underline the fractionation of executive functioning , 2011, Journal of psychopharmacology.

[28]  C. Jang,et al.  Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta25–35-induced learning and memory impairments in mice , 2011, Neuroscience Letters.

[29]  Huadong Zhou,et al.  Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats. , 2010, European journal of pharmacology.

[30]  M. Sokabe,et al.  DMXB (GTS‐21) ameliorates the cognitive deficits in beta amyloid  25–35 − injected mice through preventing the dysfunction of alpha7 nicotinic receptor , 2010, Journal of neuroscience research.

[31]  Jincai Wang,et al.  Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  V. Tancredi,et al.  Phosphorylation Changes of CaMKII, ERK1/2, PKB/Akt Kinases and CREB Activation During Early Long-Term Potentiation at Schaffer Collateral-CA1 Mouse Hippocampal Synapses , 2010, Neurochemical Research.

[33]  G. Du,et al.  Protective effect of stilbenes containing extract-fraction from Cajanus cajan L. on Aβ25–35-induced cognitive deficits in mice , 2009, Neuroscience Letters.

[34]  Jin-Tai Yu,et al.  Calcium dysregulation in Alzheimer's disease: From mechanisms to therapeutic opportunities , 2009, Progress in Neurobiology.

[35]  Xavier Barril,et al.  Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease. , 2009, Journal of medicinal chemistry.

[36]  M. Giovannini,et al.  Cholinesterase inhibitors and beyond. , 2009, Current Alzheimer research.

[37]  Ilya Bezprozvanny,et al.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.

[38]  Kim N. Green,et al.  Linking Calcium to Aβ and Alzheimer's Disease , 2008, Neuron.

[39]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[40]  B. Seltzer,et al.  Donepezil: an update , 2007, Expert opinion on pharmacotherapy.

[41]  B. Pakkenberg,et al.  A neural cell adhesion molecule–derived peptide reduces neuropathological signs and cognitive impairment induced by Aβ25-35 , 2007, Neuroscience.

[42]  J. Ieni,et al.  The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor , 2006, British journal of pharmacology.

[43]  J. Lucas,et al.  Full Reversal of Alzheimer's Disease-Like Phenotype in a Mouse Model with Conditional Overexpression of Glycogen Synthase Kinase-3 , 2006, The Journal of Neuroscience.

[44]  A. Akaike,et al.  Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons. , 2005, European journal of pharmacology.

[45]  H. Ogura,et al.  Protective effect of donepezil against Aβ(1-40) neurotoxicity in rat septal neurons , 2005, Brain Research.

[46]  P. Ghisdal,et al.  Intraneuronal amyloid‐β1‐42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death , 2004, Journal of neurochemistry.

[47]  M. Onufriev,et al.  Amyloid-β(25–35)-induced memory impairments correlate with cell loss in rat hippocampus , 2004, Physiology & Behavior.

[48]  M. Onufriev,et al.  Single intracerebroventricular administration of amyloid-beta (25–35) peptide induces impairment in short-term rather than long-term memory in rats , 2003, Brain Research Bulletin.

[49]  C. Herron,et al.  A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. , 2003, Journal of neurophysiology.

[50]  F. LaFerla.  Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.

[51]  M. Yamakage,et al.  Calcium channels — basic aspects of their structure, function and gene encoding; anesthetic action on the channels — a review , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[52]  D. K. Berg,et al.  Voltage-Gated Channels Block Nicotinic Regulation of CREB Phosphorylation and Gene Expression in Neurons , 2001, Neuron.

[53]  T. Aosaki,et al.  Deficiency of presenilin‐1 increases calcium‐dependent vulnerability of neurons to oxidative stress in vitro , 2001, Journal of neurochemistry.

[54]  D. Small,et al.  Alzheimer's disease and Aβ toxicity: from top to bottom , 2001, Nature Reviews Neuroscience.

[55]  R. Doody,et al.  Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease , 2001, Dementia and Geriatric Cognitive Disorders.

[56]  H. Shibasaki,et al.  α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity* , 2001, The Journal of Biological Chemistry.

[57]  H. Sugimoto,et al.  Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. , 2000, Current medicinal chemistry.

[58]  A. Privat,et al.  In vitro aggregation facilitates β-amyloid peptide-(25–35)-induced amnesia in the rat , 1997 .

[59]  A. Privat,et al.  Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction , 1996, Brain Research.

[60]  Alcino J. Silva,et al.  Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein , 1994, Cell.

[61]  B. K. Park,et al.  An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes. , 1993, Biochemical pharmacology.

[62]  T. Narahashi,et al.  Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells , 1993, Brain Research.

[63]  P. Kostyuk,et al.  Calcium currents in aged rat dorsal root ganglion neurones. , 1993, The Journal of physiology.

[64]  R. Nicoll,et al.  An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation , 1989, Nature.

[65]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[66]  M. Dixon.  The determination of enzyme inhibitor constants. , 1953, The Biochemical journal.

[67]  Q. Tian,et al.  Novel multipotent AChEI-CCB attenuates hyperhomocysteinemia-induced memory deficits and Neuropathologies in rats. , 2014, Journal of Alzheimer's disease : JAD.

[68]  Patrick G Kehoe,et al.  Calcium channel blockers and Alzheimer's disease: potential relevance in treatment strategies of metabolic syndrome. , 2012, Journal of Alzheimer's disease : JAD.

[69]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[70]  M. Sabbagh,et al.  Donepezil: potential neuroprotective and disease-modifying effects. , 2008, Expert opinion on drug metabolism & toxicology.

[71]  B. Pakkenberg,et al.  A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35. , 2007, Neuroscience.

[72]  A. Privat,et al.  In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat. , 1997, European journal of pharmacology.

[73]  B. Pitt.  Psychopharmacology , 1968, Mental Health.